Technology in trials: Early results promising for presbyopia reversal


Orlando-Early results from a clinical trial for the reversal and treatment of presbyopia, using SurgiLight Inc.'s OptiVision technology, appear "promising," according to researchers at New York-Presbyterian Hospital Weill Cornell Medical Center.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.